We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Use of Ultrasound, CT, CTE, and MRE to Predict the Severity of Crohn's Disease Compared

By MedImaging International staff writers
Posted on 23 Mar 2015
Print article
Researchers have reported on the results of a study investigating the effectiveness of ultrasound, for patients with Crohn's disease.

Scientists at the University of Calgary (Calgary, AB, Canada) assessed the equivalence of transabdominal ultrasound, temporally related Computed Tomography (CT), Computed Tomography Enterography (CTE), and Magnetic Resonance Enterography (MRE) for predicting disease activity and intestinal complications in patients with Crohn's disease.

The researchers made a retrospective analysis of 308 consecutive patients suffering from Crohn's disease, all of whom had ultrasound, CT, CTE, and MRE scans, without any intervening therapy. The scans were independently reviewed and graded by specialty-physicians for overall disease activity, bowel wall thickening, presence of inflammatory fat, and mural blood flow, with the intent to identify and report complications.

The results showed disease activity grades on ultrasound and reference imaging were concordant in 98.05% of patients on the basis of wall thickness, 87.13% with respect to inflammatory fat, and 96.69% on the basis of blood flow.

The researchers concluded that the use of transabdominal ultrasound was equivalent to, and even superior in some cases, to either CT or CTE/MRE in predicting disease activity and clinical complications in Crohn's disease. The researchers also concluded that ultrasound could be used effectively as a first line investigation tool for emergency and routine surveillance of the disease.

The researchers reported their findings at the 2015 European Congress of Radiology (ECR) in Vienna (Austria).

Related Links:

University of Calgary


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
X-Ray QA Meter
Piranha CT
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Ultrasound Needle Guide
Ultra-Pro II

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.